1. Home
  2. LPLA vs DXCM Comparison

LPLA vs DXCM Comparison

Compare LPLA & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LPL Financial Holdings Inc.

LPLA

LPL Financial Holdings Inc.

HOLD

Current Price

$364.03

Market Cap

29.9B

Sector

Finance

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$72.78

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPLA
DXCM
Founded
1989
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9B
25.9B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
LPLA
DXCM
Price
$364.03
$72.78
Analyst Decision
Buy
Strong Buy
Analyst Count
11
22
Target Price
$422.64
$86.41
AVG Volume (30 Days)
506.7K
5.1M
Earning Date
01-29-2026
02-12-2026
Dividend Yield
0.33%
N/A
EPS Growth
N/A
7.75
EPS
10.69
1.80
Revenue
$15,163,188,000.00
$4,515,900,000.00
Revenue This Year
$42.16
$17.41
Revenue Next Year
$24.46
$12.73
P/E Ratio
$33.86
$40.55
Revenue Growth
34.55
14.21
52 Week Low
$262.83
$54.11
52 Week High
$403.58
$93.25

Technical Indicators

Market Signals
Indicator
LPLA
DXCM
Relative Strength Index (RSI) 47.34 64.56
Support Level $366.53 $68.54
Resistance Level $380.56 $75.98
Average True Range (ATR) 11.67 2.80
MACD 0.11 0.33
Stochastic Oscillator 27.68 71.02

Price Performance

Historical Comparison
LPLA
DXCM

About LPLA LPL Financial Holdings Inc.

LPL Financial is the largest US independent broker-dealer, with nearly 29,000 financial advisors affiliated with its platform and roughly 10 million associated customer accounts at the end of 2024. The firm earns the bulk of its profit from interest income earned on client cash balances and from advisory fees and commissions tied to the $1.7 trillion in assets under management or advisory on its platform at year-end 2024. LPL specializes in the provision of turnkey wealth management services for affiliated independent advisors, but maintains a diverse array of affiliation modalities, running the gamut from more traditional employee models to a pure RIA custody approach. It earns tuck-in revenue from recordkeeping fees and the provision of software tools and services to its advisor base.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: